Guangzhou China, July 21, 2011 - Guilin Layn Natural Ingredients Corp. (Guilin Layn), engaged in production of plant extracts, may turn loss into gain in H2 2011, thanks to its rapidly increasing sales of momordica glycosides (a natural sweetener).
Although it is estimated that Guilin Layn's amount of loss may reach about USD1-1.5 million in H1 2011 according to its financial report of the first quarter of 2011, Guilin Layn may successfully make a profit in light of the following factors.
Natural sweeteners, such as momordica glycosides and stevia sweetener, have become more and more popular among consumers in some developed countries in recent years, such as the US, Japan and South Korea.
Compared with artificial high intensity sweeteners, natural sweeteners are safer to be used as food additives. With the enhancement of consumers' health awareness in the world, more and more foods and health products will use natural sweeteners as additives.
Guilin Layn successfully got the GRAS (Generally Recognized as Safe) certification of momordica glycosides from FDA (Food and Drug Administration of the US) in April 2011, which is very helpful for Guilin Layn to enter the sweetener market in North America. Guilin Layn's total sales value of stevioside has reached about USD100 million in 2010 after FDA granted stevia sweetener the GRAS certification in 2009, according to Mr. Liao, General Manager of Guilin Layn. Meanwhile, Guilin Layn has been preparing for the construction of a new branch named Layn USA Inc. located in the US since Oct. 2010, in order to efficiently promote the momordica glycosides in North America. It is predictable that Guilin Layn's sales value of momordica glycosides may obviously soar in H2 2011.
Moreover, Guilin Layn has completed the construction and started the trial running of new production lines in June 2010. Its processing capacity of raw materials will increase from 3,000t/a to 7,000t/a after the new production lines are formally launched in H2 2011.
Currently, Guilin Layn owns the extraction processes of about 200 kinds of plant extracts and 18 national invention patents. Especially, Guilin Layn has got a national invention patent of momordica glycosides extraction as early as 2004, which has laid the root for its currently leading position in Chinese momordica glycosides market. Moreover, Guilin is the major production area of grosvener siraitia and can provide Guilin Layn with sufficient raw materials to produce momordica glycosides.
Source: Sweenter China News 1107
About CCM
CCM is dedicated to market research in China, Asia-Pacific Rim and global market. With a staff of more than 150 dedicated highly-educated professionals. CCM offers Market Data, Analysis, Reports, Newsletters, Buyer-Trader Information, Import/Export Analysis all through its new proprietary product ValoTracer.
Please visit http://www.cnchemicals.com for more information or contact econtact@cnchemicals.com
CCM International Ltd.
Guangzhou CCM Information Science & Technology Co., Ltd.
17th Floor, Huihua Commercial & Trade Mansion, No.80 Xianlie Zhong Road, Guangzhou 510070, China